Your browser doesn't support javascript.
loading
Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.
Clelland, Elle N; Rothschild, Harriet T; Patterson, Anne; Molina-Vega, Julissa; Kaur, Mandeep; Symmans, W Fraser; Schwartz, Christopher J; Chien, A Jo; Benz, Christopher C; Mukhtar, Rita A.
Afiliación
  • Clelland EN; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Rothschild HT; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Patterson A; Department of Surgery, University of California, 1825 4th Street, 3rd Floor, Box 1710, San Francisco, CA, 94143, USA.
  • Molina-Vega J; Department of Surgery, University of California, 1825 4th Street, 3rd Floor, Box 1710, San Francisco, CA, 94143, USA.
  • Kaur M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Symmans WF; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Schwartz CJ; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
  • Chien AJ; Department of Medicine, University of California, San Francisco, San Francisco, USA.
  • Benz CC; Cancer & Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, USA.
  • Mukhtar RA; Department of Surgery, University of California, 1825 4th Street, 3rd Floor, Box 1710, San Francisco, CA, 94143, USA. rita.mukhtar@ucsf.edu.
Breast Cancer Res Treat ; 202(2): 367-375, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37500962

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Lobular Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Lobular Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos